Sector: Health Care.Industry: Life Sciences Tools & Services
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-04-29 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 1.830 | 1.900 | 0.0700 | ||||
| REV | 751.010M | 760.229M | 9.219M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ICLR | Icon | -0.3% | 10.5B |
Icon Company Questions & Answers
Q
How do I buy Icon (ICLR) stock?
A
You can purchase shares of Icon (NASDAQ: ICLR) through any online brokerage.
Q
Who are Icon's (ICLR) main competitors?
A
Other companies in Icon’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS) and PPD (NASDAQ:PPD).
Q
What is the target price for Icon?
A
The latest price target for Icon (NASDAQ: ICLR) was reported by Wells Fargo on 2021-04-01. The analyst firm set a price target for 235.00 expecting ICLR to rise to within 12 months (a possible 18.64% upside). 20 analyst firms have reported ratings in the last year.
Q
How much is Icon (ICLR) stock ?
A
The stock price for Icon (NASDAQ: ICLR) is $198.07 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
Q
When is the next Icon (ICLR) dividend?
A
There are no upcoming dividends for Icon.
Q
When is Icon (NASDAQ:ICLR) reporting earnings?
A
Icon’s Q1 earnings are confirmed from now on April 29, 2021.
Q
When is the upcoming split for ICLR?
A
There is no upcoming split for Icon.